Zantac Cancer Lawsuit
Zantac, a drug used to treat gastrointestinal issues such as heartburn and acid reflux, contains ranitidine, a substance that has been linked to various cancers. Allegations have surfaced that Zantac and its manufacturers failed to adequately warn consumers about the potential risks.
Last updated May 25, 2026
•ACTIVE CASES
TOP ESTIMATE
RISK OF GASTRIC/ESOPHAGEAL CANCER
STATUTE WINDOW
OVERVIEW
Zantac Cancer Lawsuit Overview
What is Zantac?
Zantac (ranitidine) is a medication commonly used to treat heartburn and acid reflux. It has been a widely prescribed drug for many years.
The Cancer Link
Long-term use of Zantac can lead to the formation of N-Nitrosodimethylamine (NDMA), a substance classified as a carcinogen. Studies suggest that this chemical could contribute to various cancers.
Manufacturer's Liability
Plaintiffs claim the manufacturers of Zantac failed to warn the public about the risks of NDMA contamination in ranitidine, despite the potential for cancer.
Who is eligible?
Individuals who have been diagnosed with cancers such as stomach, pancreatic, or esophageal cancer after prolonged use of Zantac may be eligible for legal action.
The Complete Zantac Cancer Lawsuit Guide
FREE PDF • 47 PAGES
The Complete Zantac Cancer Lawsuit Lawsuit Guide
Individuals who have been diagnosed with cancers such as stomach, pancreatic, or esophageal cancer after prolonged use of Zantac may be eligible for legal action.
LITIGATION PROGRESS
Zantac Cancer Lawsuit Timeline
April 2026
Delaware court dismissed 80,000 cases due to lack of evidence supporting cancer claims.
March 2026
Pennsylvania federal judge dismissed a securities fraud class action against GlaxoSmithKline over Zantac.
January 2026
Connecticut court scheduled bellwether trials for colorectal cancer in March 2028, stomach cancer in September 2028, and prostate cancer in early 2029.
2025
Illinois jury ruled in favor of Boehringer Ingelheim, rejecting the claim linking Zantac to kidney cancer.
Estimated Payout
What Influences Your Claims
Type of Injury Reported
Cancers commonly linked to ranitidine, including pancreatic, stomach, and bladder cancer, play a key role in evaluating the case.
Medical Records
Diagnosis dates, treatment history, and pathology reports help establish the connection between Zantac use and the reported injury.
Supporting Evidence
Prescription records, receipts, and other purchase details can strengthen the claim by showing Zantac usage.
*Claim outcomes depend on diagnosis, timing, and medical records. Similar cases may be valued differently based on each person’s circumstances.
Find a lab nearby
Locate certified MRI and neurology imaging centers to obtain the diagnostic records needed to support your claim.
What to request : Ask for a contrast-enhanced brain MRI specifically looking for meningioma. Request both the radiologist's report and the imaging CD both are needed for your legal claim.
The process
How it works
From submission to attorney match, every case follows the same four-step review.
Submit your case
Answer a short questionnaire about Zantac use and diagnosis.
Initial review
A specialist reviews your submission and checks eligibility.
Case manager call
You may be contacted to discuss medical history and records.
Attorney match
If eligible, your case may be referred to a lawyer handling similar claim.
References
SOURCES
Updated May 25, 2026
Medical News Today
Zantac cancer risk by type and safe alternatives
FDA Report on Zantac
FDA Report on Zantac
National Library of Medicine
The Association between Ranitidine Use and Gastrointestinal Cancers - PMC
United States Judicial Panel on Multidistrict Litigation (Zantac)
MDL-2924-Tag-Along-Transfer-1-22.pdf
MDL Statistics Report
CM/ECF for JPML (LIVE)
BBC News
Pharmaceuticals giant GSK to pay $2.2bn to settle Zantac lawsuits
Free Case Evaluation
Check your eligibility today.
Estimated Range